Mendus’ major shareholders and members of the Board of Directors and Management declare their intention to exercise warrants of series TO3

What we doOur approachPipelineTechnologyPatient Stories
About usManagementBoardClinical Advisory BoardCareers
Newsroom
InvestorsPress releases

Back
Mendus’ major shareholders and members of the Board of Directors and Management declare their intention to exercise warrants of series TO3
 8:05:00 AM

Keep reading
The exercise period for warrants of series TO3 commences todayRead